本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Aytu BioScience, Inc.

1.11
+0.06005.71%
盘后1.110.00000.00%17:15 EDT
成交量:3.10万
成交额:3.34万
市值:684.85万
市盈率:-0.58
高:1.11
开:1.06
低:1.05
收:1.05
数据加载中...
2023/11/15

重要事件披露

Form 8-K - Current report
2023/11/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/26

重要事件披露

Form 8-K - Current report
2023/10/13

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/10/06

重要事件披露

Form 8-K - Current report
2023/09/27

重要事件披露

Form 8-K - Current report
2023/08/15

重要事件披露

Form 8-K - Current report
2023/07/31

重要事件披露

Form 8-K - Current report
2023/07/10

重要事件披露

Form 8-K - Current report
2023/06/24

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/06/17

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/06/16

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/06/12

重要事件披露

Form 8-K - Current report
2023/06/09

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2023/06/07

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2023/06/07

SEC问询函

Form CORRESP - Correspondence
2023/06/07

SEC问询函

Form CORRESP - Correspondence
2023/06/06

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/05/27

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/05/22

重要事件披露

Form 8-K - Current report